Controlling the HIV epidemic depends on shifting from fragmented, donor-led programmes to nationally led, integrated health systems. To accompany a new joint Series of six papers, Peter Hayward, Editor-in-chief of The Lancet HIV, and Gavin Cleaver, Senior Editor at The Lancet Global Health, are joined in conversation by Solange Baptiste, Kenneth Ngure, and Charles Holmes, who worked extensively on the Series.

Together they discuss withstanding external funding shocks, meaningful community involvement, and focusing on health equity, as part of a sustainable approach to HIV prevention in Africa.

Click here to read the full series: https://www.thelancet.com/series-do/sustainable-hiv-prevention-africa

Continue this conversation on social!
Follow us today at...
https://thelancet.bsky.social/
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv

Acting Senior Editor at The Lancet Global Health Gavin Cleaver speaks with Dr. Nareen Daruwalla about her latest research on the prevention of domestic violence in communities in India, published in our December issue.

Dr. Daruwalla offers insights from her extensive career in violence prevention and community intervention, explains why domestic violence is a major public health concern, and reflects on the challenges and successes of implementing grassroots prevention programmes and changing the conversation on domestic violence.

Click here to read the full article: https://www.thelancet.com/journals/langlo/article/PIIS2214-109X(25)00358-4/fulltext

Continue this conversation on social!
Follow us today at...
https://thelancet.bsky.social/
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv

70 years ago this year, a researcher at University College of the West Indies in Jamaica published a paper in The Lancet describing a case series of patients with diabetes who did not have the typical hallmarks of type 1 or type 2 disease. They were young, underweight, resistant to insulin, and did not tend to have ketoacidosis.

The condition was coined J-type diabetes, after Jamaica, and it was briefly recognised by WHO as malnutrition-related diabetes. However, WHO removed it from its official classification in 1999, because of insufficient evidence of its association with malnutrition.

In this episode of In Conversation With, Professor Meredith Hawkins and Professor Nihal Thomas explain how this “lost” condition, which they estimate affects 25 million people worldwide, particularly in low- and middle-income countries, is now becoming more widely recognised and better understood, albeit with a long way to go in terms of additional research. They also propose a new name: type 5 diabetes. Listen now to explore the fascinating history of the disorder and the urgent need for effective treatments.

Read the full Viewpoint:

https://www.thelancet.com/journals/langlo/article/PIIS2214-109X(25)00263-3/fulltext?dgcid=buzzsprout_icw_podcast_September_25_langlo

Continue this conversation on social!
Follow us today at...
https://thelancet.bsky.social/
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv